Somavert
Active Ingredient(s): PegvisomantFDA Approved: * March 25, 2003
Pharm Company: * PHARMACIA AND UPJOHN
Category: Acromegaly
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Somavert Overview
Pegvisomant (trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly.[1] It is primarily used if the pituitary gland tumor causing the acromegaly cannot be controlled with surgery or radiation, and the use of somatostatin analogues is unsuccessful, but is also effective as a monotherapy.[2] It is delivered as a powder that is mixed with water and injected under the skin.[3] Contents 1 Discovery 2 Struct...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pegvisomant
Recent Somavert Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Pegvisomant
- Injection: 10mg/vial, 15mg/vial, 20mg/vial, 25mg/vial, 30mg/vial
- Powder for Reconstitution: 10mg, 15mg, 20mg
NDC Database Records for Somavert: (10 results)
Sorted by National Drug Code- 0009-5176 Somavert Kit by Pharmacia and Upjohn Company
- 0009-5178 Somavert Kit by Pharmacia and Upjohn Company
- 0009-5180 Somavert Kit by Pharmacia and Upjohn Company
- 0009-5199 Somavert Kit by Pharmacia and Upjohn Company
- 0009-5200 Somavert Kit by Pharmacia and Upjohn Company
- 0009-7166 Somavert Kit by Pharmacia and Upjohn Company LLC
- 0009-7168 Somavert Kit by Pharmacia and Upjohn Company LLC
- 0009-7188 Somavert Kit by Pharmacia and Upjohn Company LLC
- 0009-7199 Somavert Kit by Pharmacia and Upjohn Company LLC
- 0009-7200 Somavert Kit by Pharmacia and Upjohn Company LLC